Thiazolocarboxamide Analogues as NAMPT Inhibitors

摘要

The present application claims a series of thiazolocarboxamide analogues, which inhibit the activity of nicotinamide phosphoribosyltransferase (NAMPT). The compounds claimed in this patent could potentially be useful for the development of new cancer therapies.